Search Orphan Drug Designations and Approvals
-
Generic Name: | Bis(4-fluorophenyl)phenylacetamide |
---|---|
Date Designated: | 03/02/2000 |
Orphan Designation: | Treatment of sickle cell disease. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ICAgen Inc. Ion Channel Advances PO Box 14487 Durham, North Carolina 27709 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-